Pictet Asset Management Sa 89bio, Inc. Transaction History
Pictet Asset Management Sa
- $83.4 Billion
- Q2 2023
A detailed history of Pictet Asset Management Sa transactions in 89bio, Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 3,575,126 shares of ETNB stock, worth $28.2 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
3,575,126
Previous 976,551
266.1%
Holding current value
$28.2 Million
Previous $14.9 Million
355.54%
% of portfolio
0.08%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding ETNB
# of Institutions
158Shares Held
108MCall Options Held
73.6KPut Options Held
1.19M-
Janus Henderson Group PLC London, X015.2MShares$119 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA14.2MShares$112 Million1.46% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.99MShares$63 Million2.33% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$58.1 Million0.87% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$55.3 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $366M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...